Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-25-203537

Director bought 41,666 shares at an average $24.65 ($1,027,111)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PAUL STEVEN M Director 2025-09-12 Purchase +28,284 $24.50 $692,947 28,284 I
PAUL STEVEN M Director 2025-09-12 Purchase +13,382 $24.97 $334,165 41,666 I
Open-market purchases · 41,666 sh · avg $24.65 · $1,027,111
Loading xslF345X05/ownership.xml…